Display Settings:

Format

Send to:

Choose Destination
    Can J Urol. 2005 Oct;12(5):2841-2.

    Remission of hormone-refractory prostate cancer attributed to Essiac.

    Source

    Division of Urology, The Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.

    Abstract

    Essiac is a popular complementary and alternative medicine (CAM) that is utilized by many cancer patients in North America. Much anecdotal reporting exists about its cancer-fighting qualities, but so far no clinical trials have been preformed to validate those claims. We describe here the case of a 64-year-old man whose hormone-refractory prostate cancer responded well to Essiac tea.

    PMID:
    16274521
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk